Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
Peer Exchange: Diabetes Stakeholders Summit
From Unexpected CV Benefits to Potential in Heart Failure: Insights and Outlook for SGLT2 Inhibitors
Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
A study presented at the 2017 Scientific Session of the American College of Cardiology uses claims data to examine whether SGLT2 inhibitors offer a protective benefit against heart failure.
Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
High Fiber Linked to Fewer Bowel Symptoms in CRC Survivors
3
Risk-Based Contracts May Not Cut Low-Value Care in Medicare Advantage
4
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
5
